William J. Huang

Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment

John S. Sundy, Herbert S. B. Baraf, Robert A. Yood et al. · JAMA · 2011 · 516 citations · Full text

Pharmacy, Pharmacotherapy, Biopharmaceutics +14

Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout

John S. Sundy, Nancy J. Ganson, Susan J. Kelly et al. · Arthritis & Rheumatism · 2007 · 219 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +16

Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol–conjugated uricase) in patients with treatment‐failure gout: Results of a phase II randomized study

John S. Sundy, Michael A. Becker, Herbert S. B. Baraf et al. · Arthritis & Rheumatism · 2008 · 180 citations

Medicine, Pharmacology, Pharmacotherapy +15

8-HYDROXY-2′-DEOXYGUANOSINE IN LEUKOCYTE DNA OF SPERMATIC VEIN AS A BIOMARKER OF OXIDATIVE STRESS IN PATIENTS WITH VARICOCELE

Shiou-Sheng Chen, William J. Huang, Luke S. Chang et al. · The Journal of Urology · 2004 · 55 citations

Life Sciences, Molecular Biology, Infertility +14

Population Pharmacokinetic and Pharmacodynamic Analysis of Pegloticase in Subjects With Hyperuricemia and Treatment‐Failure Gout

Corinne Seng Yue, William J. Huang, Michelle Alton et al. · The Journal of Clinical Pharmacology · 2008 · 26 citations

Medicine, Pharmacokinetics, Pharmacology +10